Navigation Links
Study identifies causes of bone loss in breast cancer survivors
Date:11/19/2008

MAYWOOD -- Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.

But a new study has found that cancer drugs aren't the only culprits. Among 64 breast cancer patients referred to a bone health clinic, 78 percent had at least one other cause of bone loss, including vitamin D deficiency, excessive calcium excretion in urine and an overactive parathyroid gland.

"Doctors evaluating breast cancer patients for possible bone loss should look further than cancer drugs," said Dr. Pauline Camacho, lead author of the study in the Journal of Clinical Oncology. Camacho is an associate professor in the department of medicine, division of endocrinology and metabolism, Loyola University Chicago Stritch School of Medicine.

A co-author of the study, Dr. Kathy Albain, said breast cancer survivors "are just like the normal population as they age in that bone loss can be due to many treatable causes." Albain is a professor in the Department of Medicine, division of hematology/oncology at Stritch.

Previous studies have found that chemotherapy drugs can cause bone loss. Studies also have found that a class of breast cancer drugs called aromatase inhibitors can decrease bone mineral density and increase the risk of fractures in postmenopausal women. Aromatase inhibitors decrease the body's production of estrogen. While estrogen feeds cancer, it also protects against osteoporosis. Aromatase inhibitors include letrozole (trade name, Femara), anastrazole (Arimidex) and exemestane (Aromasin).

Researchers reviewed charts of 238 consecutive postmenopausal patients who had osteoporosis or osteopenia and were referred to the Loyola's Osteoporosis and Metabolic Bone Disease Center from 2000 to 2006. (Osteopenia is lower than normal bone mineral density, but not low enough to be classified as osteoporosis.) The patients included 64 women with breast cancer referre
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
2. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
3. Rutgers researchers study cites media violence as critical risk factor for aggression
4. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
5. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
6. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
7. Study investigates Gore-tex-type device to stop strokes and mini-strokes
8. The smart way to study
9. Case Western Reserve University study examines working couples retirement patterns
10. Surgical study highlights pros and cons of gastric bypass surgery for severe obesity
11. Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ical legislation would strengthen Medicare, improv... 8 SUMMARY: Yesterday... critical health care reform legislation that woul...nation by insurance companies that prices millions... ,, The Affordable Health Care for America Act ...
(Date:11/8/2009)... UCW Academy of Health holds open ho...Victoria, BC (Vocus) November 8, 2009 -- UCW Acade...eer in British Columbia’s health care indust...sday, November 25, 2009. , ,UCW Academy of Health...ation, nursing and social services, designs its pr...
(Date:11/8/2009)...NGTON, Nov. 7 Tonight t...Health Care for America Act, landmark health refor...access to quality, affordable, stable and secure h... down on some of the insurance industry,s worst pr...cans and cut the deficit by $104 billion over ten ...
(Date:11/8/2009)... Men’s Health Network (MHN) ur...risks, especially those linked to exposure to chem...ry service. Bladder cancer is one of those cancers...ecially those who once smoked or currently smoke c...C (PRWEB) November 8, 2009 -- Men’s Health N...
(Date:11/8/2009)...on,s largest network of Hispanic health advocates ...rm in 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-U...atives showed they have heard the voice of America...for America Act. Now the Senate must deliver, with...e reform," said Dr. Jane L. Delgado, President and...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...nic gastrointestinal symptoms are highly prevalent...ious gastrointestinal symptoms that greatly inconv...ude GERD, uninvestigated dyspepsia, irritable bowe...valuating the impact of chronic gastrointestinal s...
...NION CITY, Calif., Dec. 29 Abaxis, Inc.,(Nasdaq: ... point-of-care blood,analysis systems, announced t...tive officer will present at Needham & Company...ew York City. , About Abaxis , Abaxis deve...
... could help them avoid long-term complications of ...ONDAY, Dec. 29 (HealthDay News) -- Obese teenagers...ght but see their type 2 diabetes disappear, a new... eat. In this study, researchers used the Roux-en-...
...NNATI, Dec. 29 The LCA-Vision Inc. (Nasdaq: LCA...t solicitation threatened by the Joffe group. The...prudent and achievable strategic plan to return th...at the Joffe effort is an undue distraction to the...
... In the slums of Jinja, the sec...arly scarce. Through PROJECT C.U.R.E.,s partnershi...ximately $1 million worth of medical supplies and ...s of people. The first container, filled with near...
... Home of the world,s high docum...nics of Georgia (RCOG), has expanded their online ...formation and treatment options. The company is pr...lass cancer treatment and is viewed as a leader in...
Other Medicine News:Health News:Chronic gastrointestinal symptoms in Korean population 2Health News:Gastric Bypass Halts Diabetes in Obese Teens 2Health News:Gastric Bypass Halts Diabetes in Obese Teens 3Health News:LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Group's Threatened Consent Solicitation 2Health News:American-Based NGO Sends Emergency Medical Relief to Uganda 2Health News:RCOG.com and ProstRcision.com Increase Online Presence for Cancer Information 2Health News:RCOG.com and ProstRcision.com Increase Online Presence for Cancer Information 3Health News:RCOG.com and ProstRcision.com Increase Online Presence for Cancer Information 4
(Date:11/6/2009)...e-FirstCall/ -- Boston Scientific Corporation (NYS...greement in principle with the U.S. Department of ... by its Guidant subsidiary in 2005. The alleged c...Scientific,s 2006 acquisition of Guidant. ,, Bo...igation by the U.S. Attorney,s Office in Minneapol...
(Date:11/6/2009)...wire/ -- Philips Respironics applauds the efforts ...(CDC) to raise awareness about an important public...CDC,s release of the first-ever government study t...ess is a milestone in quantifying the size and sco... industry leader and sleep therapy manufacturer, P...
(Date:11/6/2009)...rstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA...ment of small-molecule therapeutics for the treatm...us (HIV), today reported recent accomplishments an... months ended September 30, 2009. ,, (Logo: ...LOGO ) ,, "Since our last quarterly update, we ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 1CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 2No More Drama With TOMA LECHE 50310 1No More Drama With TOMA LECHE 50310 2No More Drama With TOMA LECHE 50310 3No More Drama With TOMA LECHE 50310 4Maybe Men Arent So Picky After All 50309 1Maybe Men Arent So Picky After All 50309 2
...e initial dose in an ongoing Phase Ib trial demons... three days , , Conference Call Today at 8:30AM E..., Inc. (Nasdaq: ANDS ) today announced results f...al trial of ANA598, the Company,s investigational ...ery well-tolerated and demonstrated potent antivir...
...rive the Increase , , WHITE PLAINS, N.Y., Jan. 7 ...s-long rise in the United States preterm birth rat...reased risk of death and disability according to t... born too soon in 2006, according to the National ... "Births: Final data for 2006," National Vital Sta...
Other Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2
20MPX Digital Microscope Camera
QuantiFIRE 4-Megapixel Thermoelectrically-Cooled Digital Microscope Camera
MicroFire Digital Microscope Camera
...t technologically advanced Micro-dermabrasion mach...sive research, it offers the therapist safety, and... flexibility in skin exfoliation. It is superior t...sues are biologically respected. Through regular s...
Medicine Products: